Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
NIH to test Pfizer's Paxlovid, other treatments as potential long Covid therapies
01:56pm, Monday, 31'st Jul 2023
There is no proven treatment for long Covid-19, which can cause a range of debilitating symptoms in millions of Americans.
US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapies
12:08pm, Monday, 31'st Jul 2023
The U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer's Paxlovid, in patients with symptoms of l
Week Heavy on Labor Data Commences
11:53am, Monday, 31'st Jul 2023
Week Heavy on Labor Data Commences.
How Will Pfizer's (PFE) Key Drugs Perform in Q2 Earnings?
11:53am, Monday, 31'st Jul 2023
Higher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like Vyndaqel/Vyndamax are likely to have contributed to Pfizer's (PFE) sales growth in Q2.
SOFI, ON Beat in Q2, Ahead of Jobs Week
11:08am, Monday, 31'st Jul 2023
Pre-market levels are up modestly at this hour, staying in the green much the way we ended last week after taking a breather with last Thursday's selloff.
BP, Greggs and Diageo results due on Tuesday, plus Pfizer in US
11:01am, Monday, 31'st Jul 2023
On Tuesday comes big oil, booze and sausage rolls, with BP PLC (LSE:BP.) and Greggs.
3 Pharma Stocks to Buy for Their Promising Progress
05:34am, Monday, 31'st Jul 2023
Identifying promising pharma stocks is no small feat in the dynamic and competitive realm of pharmaceuticals. The industry is replete with businesses boasting robust pipelines, each vying for a breakt
AstraZeneca reveals a $1.0 billion deal with Pfizer
06:07pm, Saturday, 29'th Jul 2023
AstraZeneca plc (LON: AZN) was in focus on Friday after the pharma giant announced a deal worth up to $1.0 billion with its U.S. peer Pfizer Inc (NYSE: PFE). Details of the AstraZeneca-Pfizer deal The
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here's why
09:00am, Saturday, 29'th Jul 2023
Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September.
Dividend Stock Watch List: Lanny's August 2023 Edition
01:40am, Saturday, 29'th Jul 2023
Dividend Stock Watch List: Lanny's August 2023 Edition
AstraZeneca Shares Surge After Revenue Beat on Cancer Drug Sales, $1 Billion Pfizer Deal
12:05pm, Friday, 28'th Jul 2023
AstraZeneca's shares rose on Friday after it announced the purchase of Pfizer's rare disease portfolio for up to $1 billion and reported better-than-expected financial results on strong sales of its c
7 Best Cancer Stocks to Invest in Now
07:00am, Friday, 28'th Jul 2023
One of the most aggressive and difficult-to-treat ailments, cancer is a disease that involves the uncontrolled division and growth of malignant cells. There are many types of cancer, many of which hav
AstraZeneca unit strikes $1bn rare diseases deal with Pfizer
02:41am, Friday, 28'th Jul 2023
AstraZeneca PLC's rare disease unit, Alexion, has unveiled a $1 billion agreement to acquire Pfizer's early-stage gene therapy portfolio, a strategic move designed to bolster its footprint in the bur
AstraZeneca signs $1 bln deal with Pfizer for gene therapy portfolio
02:16am, Friday, 28'th Jul 2023
AstraZeneca said on Friday its unit Alexion has agreed to buy a portfolio of U.S. drugmaker Pfizer's early-stage rare disease gene therapy for up to $1 billion, plus royalties on sales.
As syphilis cases rise and supply of a key treatment runs short, federal health officials are forming a task force to address the threat
03:10pm, Thursday, 27'th Jul 2023
The U.S. Department of Health and Human Services is proposing a federal task force to lead the public-health response to a surge in syphilis cases, a department spokesperson told MarketWatch Thursday.
